INFORMATICS METHODS TO EVALUATE LOW RISK FEBRILE NEUTROPENIA RISK STRATIFICATION MODELS IN LEUKEMIA

被引:0
|
作者
Lewing, Karen [1 ]
Wood, Nicole [1 ]
Davis, Sierra [1 ]
Noel-MacDonnell, Janelle [1 ]
Glynn, Earl [1 ]
Hoffman, Mark [1 ]
机构
[1] Childrens Mercy Kansas City, Kansas City, MO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
028
引用
收藏
页码:S27 / S28
页数:2
相关论文
共 50 条
  • [21] SIGNIFICANCE OF FEBRILE NEUTROPENIA RISK SCORE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Vidovic, A.
    Virijevic, M.
    Djunic, I.
    Tomin, D.
    Vukovic, N. Suvajdzic
    Colovic, N.
    Mitrovic, M.
    Arsenijevic, V. Arsic
    Pavlovic, S.
    Mihaljevic, B.
    HAEMATOLOGICA, 2014, 99 : 574 - 575
  • [22] Procalcitonin vs C-Reactive Protein, Biomarkers for Risk Stratification of Febrile Neutropenia among the Children with Acute Leukemia
    Jamal, C.
    Nahar, A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S156 - S157
  • [23] Low-risk febrile neutropenia in a medical oncology unit
    Leong, DCS
    Kinlay, S
    Ackland, S
    Bonaventura, A
    Stewart, JF
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (04): : 403 - 407
  • [24] Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia
    Karthaus, M
    Wolf, HH
    Kampfe, D
    Egerer, G
    Ritter, J
    Peters, G
    Sudhoff, T
    Franke, A
    Heil, G
    Kullmann, KH
    Jurgens, H
    CHEMOTHERAPY, 1998, 44 (05) : 343 - 354
  • [25] Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia
    Pal, Khushboo V.
    Othus, Megan
    Ali, Zahra
    Russell, Katherine
    Shaw, Carole
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Appelbaum, Jacob S.
    Walter, Roland B.
    Halpern, Anna B.
    BLOOD ADVANCES, 2024, 8 (24) : 6161 - 6170
  • [26] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Kyung Soo Lim
    Jae-Lyun Lee
    Supportive Care in Cancer, 2013, 21 : 2303 - 2308
  • [27] Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lim, Kyung Soo
    Lee, Jae-Lyun
    SUPPORTIVE CARE IN CANCER, 2013, 21 (08) : 2303 - 2308
  • [28] Outpatient management of febrile neutropenia associated with cancer chemotherapy: Risk stratification and treatment review
    Pherwani, Nisha
    Ghayad, Joanna M.
    Holle, Lisa M.
    Karpiuk, Emilie L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (08) : 619 - 631
  • [29] A survey of parent and staff views on management by risk stratification in children with febrile neutropenia (FN)
    Laddie, Joanna
    Chisholm, Julia
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 508 - 509
  • [30] Provider familiarity with specialty society guidelines for risk stratification and management of patients with febrile neutropenia
    Baughmd, Christopher W.
    Brooks, Gabriel A.
    Reust, Audrey C.
    Wang, Thomas J.
    Caterino, Jeffrey M.
    Baker, Olesya N.
    Pallin, Daniel J.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (08): : 1704 - 1705